Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis-Reference-Cited by-同舟云学术

Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis

Published:2018-11-02 Issue:7 Volume:37 Page:1377-1387
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Zheng Xiaonan,Qiu Yuxuan,Qiu Shi,Tang Liansha,Nong Kailei,Han Xin,Li Min,Quan Liuliu,Yang Lu,Wei Qiang^ORCID

Funder

National key research and development program of China

National Natural Science Foundation of China

Prostate Cancer Foundation

Programs from Science and Technology Department of Sichuan Province

Young Investigator Award of Sichuan University 2017

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-018-2530-1.pdf

Reference33 articles.

1. Parsons JK (2010) Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 5(4):212–218. https://doi.org/10.1007/s11884-010-0067-2

2. Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173(4):1256–1261. https://doi.org/10.1097/01.ju.0000155709.37840.fe

3. Knapp GL, Chalasani V, Woo HH (2017) Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser. BJU Int 119(Suppl 5):33–38. https://doi.org/10.1111/bju.13822

4. Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038

5. Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Thomas JA (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial—the GOLIATH study. Eur Urol 65(5):931–942. https://doi.org/10.1016/j.eururo.2013.10.040

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ablative Procedures—Vaporization: Bipolar and Photoselective Vaporization of the Prostate;Benign Prostate Syndrome;2023

2. Comparison of PKRP and TUVP in the treatment of high-risk BPH and analysis of postoperative influencing factors;Frontiers in Surgery;2022-08-03

3. Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients;Frontiers in Surgery;2022-05-17

4. Surgical treatment options for benign prostatic obstruction: beyond prostate volume;Current Opinion in Urology;2022-01

5. From “micro-” diagnosis to “macro-” treatment, a road full of colors;Hellenic Urology;2022